President, Head of CMC & Manufacturing
I-MAB
Dr. Zheru Zhang has over 20 years of biologics CMC industry experiences in US, Korea and China. He is the president of I-MAb, Shanghai. Prior to current job, he was CEO of Shanghai JMT-Bio Inc. (now part of CSPC), President of Tasgen (one of the predecessors of I-Mab). He was involved in the creation of I-Mab.
Dr. Zhang also worked for Bristol Myers Squibb in NJ, Johnson & Johnson (Centocor) in PA, and Celltrion in Incheon, Korea and contributed to over 25 IND and BLA filings.